Abstract
Since clozapine is, in contrast to conventional neuroleptics, effective in treatment refractory schizophrenic patients its mechanism of action may be different from that of typical neuroleptics. Clozapine has been shown to display the highest binding affinity of all neuroleptics to one of the serotonin (5-hydroxytryptamine, 5HT) receptor subtypes, i.e., the 5HT1c receptor. Furthermore, clozapine, in contrast to conventional neuroleptics, blocks the effect of 5HT agonists on ACTH and corticosterone release in animals. This study hypothesized that clozapine, but not haloperidol would block ACTH and prolactin release induced by the 5HT agonist,m-chlorophenylpiperazine (MCPP). MCPP (0.35 mg/kg PO) was administered after a 3-week drug-free period, after 5 weeks of haloperidol treatment (20 mg/day) and finally after 5 weeks of clozapine treatment (>400 mg/day) in ten male schizophrenic patients. Clozapine, but not haloperidol, blocked the effect of MCPP on ACTH and prolactin release. These results suggest that clozapine, in contrast to haloperidol, is a functional 5HT antagonist. Since MCPP-induced ACTH and prolactin release may be (partially) 5HT1c mediated, these results suggest that clozapine is a potent antagonist at the 5HT1c receptor.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Altar CA, Wasley AM, Neale RF, Stone GA (1986) Typical and atypical antipsychotic occupance of D2 and S2 receptors: an autoradiographic analysis in rat brain. Brain Res Bull 16:517–525
Andree TH, Mikuni M, Tong CY, Koenig JI, Meltzer HY (1986) Differencial effect of subchrnoic treatment with various neuroleptic agents on serotonin S2 receptors in rat cerebral cortex. J Neurochem 46:191–197
Bagdy G, Szemeredi K, Kanyicska B, Murphy DL (1989) Different serotonin receptors mediate blood-pressure, heart rate, plasma catecholamine and prolactin responses tom-chlorophenyl-piperazine in conscious rats. J Pharmacol Exp Ther 250:72–78
Canton H, Verriele L, Colpaert FC (1990) Binding of typical and atypical antipsychotics to 5HT1c and 5HT2 sites: clozapine potently interacts with 5HT1c sites. Eur J Pharmacol 191:93–96
Claghorn J, Honigfeld G, Abuzzahab FS, Wang R, Steinbook R, Tuason V, Klerman G (1987) The risk and benefits of clozapine versus chlorpromazine. J Clin Psychopharmacol 7:377–384
Cohen BM, Lipinski JF (1986) In vivo potencies of antipsychotic drugs in blocking alpha-1 noradrenergic and dopaminergic D2 receptors: implications for drug mechanisms of action. Life Sci 39:2571–2580
Conn PJ, Sanders-Bush E (1987) Relative efficacies of piperazines at the phosphoinositide hydrolysis-linked serotonergic 5HT2 and 5HT1c receptors. J Pharmacol Exp Ther 242:552–557
Fischer-Cornelssen KA, Ferner UJ (1976) An example of European multicenter trials: mulispectral analysis of clozapine. Psychopharmacol Bull
Heninger GR, Krystal JH, Smith A (1988) Effects of D1 and D2 receptor antagonists and 5HT receptor agonists and antagonists on neuroendocrine function in rhesus monkeys. Soc Neurosci Abstr 324.7
Jenner P, Rupniak NM, Marsden CD (1985) Differential alteration of striatal D1 and D2 receptors induced by the long-term administration of haloperidol, sulpiride or clozapine to rats. Psychopharmacology (Suppl): 174–181
Kahn RS, Wetzler S (1991)m-Chlorophenylpiperazine as a probe of serotonin receptors: a review. Biol Psychiatry 30:1139–1166
Kahn RS, Kalus O, Cahn W, Wetzler S, Asnis GM, van Praag HM (1990a) The effect of 5HT antagonists ofm-chlorophenyl-piperazine-mediated responses. Psychiatry Res 33:189–198
Kahn RS, Wetzler S, Asnis GM, van Praag HM (1990b) The effects ofm-chlorophenylpiperazine in normal subjects: a dose-response study. Psychopharmacology 100:339–344
Kahn RS, Siever L, Gabriel S, Amin F, Stern RG, DuMont K, Apter S, Davidson M (1992) Serotonin function in schizophrenia: effects ofm-chlorophenylpiperazine in schizophrenic patients and healthy subjects. Psychiatry Res 43:1–12
Kahn RS, Davidson M, Siever L, Gabriel S, Apter S, Davis KL (1993) Serotonin function and treatment response to clozapine in schizophrenic patients. Am J Psychiatry (in press)
Kane J, Honigfeld G, Singer J, Meltzer H (1988) Clozapine for the treatment-resistant schizophrenic. Arch Gen Psychiatry 45:789–796
Lee T, Tang SW (1984) Lozapine and clozapine decrease serotonin (S2) but do not elevate dopamine (D2) receptor numbers in the rat brain. Psychiatry Res 12:277–285
Leon CA (1979) Therapeutic effects of clozapine: a 4-year follow-up of a controlled clinical trial. Acta Psychiatr Scand 59:471–480
Leysen JE, Van Gompel P, Gommeren W, Woestenborghs R, Janssen PAJ (1986) Down regulation of serotonin S2 receptor sites in rat brain by chronic treatment with the serotonin S2 antagonists: ritanserin and setoperone. Psychopharmacology 88:434–444
Meltzer HY (1989) Clinial studies on the mechanism of action of clozapine: the dopamine-serotonian hypothesis of schizophrenia. Psychopharmacology 99:S18-S27
Mueller EA, Murphy DL, Sunderland T (1986) Further studies of the putative serotonin agonist,m-chlorophenylpiperazine: evidence for a serotonin receptor mediated mechanism of action in humans. Psychopharmacology 89:388–391
Nash JF, Meltzer HY, Gudelsky GA (1988) Antagonism of serotonin receptor mediated neuroendocrine and temperature responses by atypical neuroleptics in the rat. Eur J Pharmacol 151:463–469
Peroutka SJ, Snyder SH (1980) Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potence. Am J Psychiatry 137:1518–1522
Rupniak NM, Kilpatrick G, Hall MD, Jenner P, Marsden CD (1984) Differential alterations in striatal dopamine receptor sensitivity induced by repeated administration of clinically equivalent doses of haloperidol, sulpiride or clozapine in rats. Psychopharmacology 84:512–519
Seeger Th F, Thal L, Gardner EL (1982) Behavioral and biochemical aspects of neuroleptic induced dopaminergic supersensitivity: studies with chronic clozapine and haloperidol. Psychopharmacology 80 [Suppl]:182–187
Seibyl JP, Krystal JH, Price LH, Woods SW, D'Amico CD, Heninger GR, Charney DS (1991) Effects of ritanserin on the behavioral, neuroendocrine, and cardiovascular responses to metachlorophenylpiperazine in healthy subjects. Psychiatry Res 38:227–236
Suckow RF, Cooper ThB, Kahn RS (1990) High-performance liquid chromatographic method for analysis of plasmam-chlorophenylpiperazine. J Chromatogr 528:228–234
Van Praag HM, Korf J, Dols LCW (1976) Clozapine versus perphenazine: the value of the biochemical mode of action of neuroleptics in predicting their therapeutic efficacy. Br J Psychiatry 129:547–555
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kahn, R.S., Siever, L., Davidson, M. et al. Haloperidol and clozapine treatment and their effect onM-chlorophenylpiperazine-mediated responses in schizophrenia: implications for the mechanism of action of clozapine. Psychopharmacology 112 (Suppl 1), S90–S94 (1993). https://doi.org/10.1007/BF02245012
Issue Date:
DOI: https://doi.org/10.1007/BF02245012